116 related articles for article (PubMed ID: 1669520)
1. Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health Study.
Cairns J; Cohen L; Colton T; DeMets DL; Deykin D; Friedman L; Greenwald P; Hutchison GB; Rosner B
Ann Epidemiol; 1991 Aug; 1(5):395-405. PubMed ID: 1669520
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers of compliance in the Physicians' Health Study.
Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
Manson JE; Buring JE; Satterfield S; Hennekens CH
Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
[TBL] [Abstract][Full Text] [Related]
4. Migraine and subsequent risk of stroke in the Physicians' Health Study.
Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of aspirin and beta-carotene among U.S. physicians.
Hennekens CH; Eberlein K
Prev Med; 1985 Mar; 14(2):165-8. PubMed ID: 3900975
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.
Steering Committee of the Physicians' Health Study Research Group
N Engl J Med; 1988 Jan; 318(4):262-4. PubMed ID: 3275899
[No Abstract] [Full Text] [Related]
7. Final report on the aspirin component of the ongoing Physicians' Health Study.
Steering Committee of the Physicians' Health Study Research Group
N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
[TBL] [Abstract][Full Text] [Related]
8. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
Hennekens CH; Buring JE; Manson JE; Stampfer M; Rosner B; Cook NR; Belanger C; LaMotte F; Gaziano JM; Ridker PM; Willett W; Peto R
N Engl J Med; 1996 May; 334(18):1145-9. PubMed ID: 8602179
[TBL] [Abstract][Full Text] [Related]
10. Estimating the effect of the run-in on the power of the Physicians' Health Study.
Lang JM; Buring JE; Rosner B; Cook N; Hennekens CH
Stat Med; 1991 Oct; 10(10):1585-93. PubMed ID: 1947514
[TBL] [Abstract][Full Text] [Related]
11. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
Buring JE; Hennekens CH
Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
[TBL] [Abstract][Full Text] [Related]
12. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.
Glynn RJ; Buring JE; Manson JE; LaMotte F; Hennekens CH
Arch Intern Med; 1994 Dec 12-26; 154(23):2649-57. PubMed ID: 7993148
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
[TBL] [Abstract][Full Text] [Related]
14. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
[TBL] [Abstract][Full Text] [Related]
15. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
Lee IM; Cook NR; Manson JE; Buring JE; Hennekens CH
J Natl Cancer Inst; 1999 Dec; 91(24):2102-6. PubMed ID: 10601381
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).
Cook NR; Le IM; Manson JE; Buring JE; Hennekens CH
Cancer Causes Control; 2000 Aug; 11(7):617-26. PubMed ID: 10977106
[TBL] [Abstract][Full Text] [Related]
17. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.
Cook NR; Cole SR; Hennekens CH
Am J Epidemiol; 2002 Jun; 155(11):1045-53. PubMed ID: 12034583
[TBL] [Abstract][Full Text] [Related]
18. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.
Cook NR; Hebert PR; Manson JE; Buring JE; Hennekens CH
Arch Intern Med; 2000 Apr; 160(7):921-8. PubMed ID: 10761956
[TBL] [Abstract][Full Text] [Related]
19. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I.
Christen WG; Ajani UA; Schaumberg DA; Glynn RJ; Manson JE; Hennekens CH
Arch Ophthalmol; 2001 Mar; 119(3):405-12. PubMed ID: 11231774
[TBL] [Abstract][Full Text] [Related]
20. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
